Fresenius Kabi Issues Voluntary U.S. Recall of Thr...
Category : Clinical Trial Update 14 November 2025Fresenius Kabi, a global healthcare company specializing in infusion, transfusion, and clinical nutr...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
DBV Technologies Completes Last Patient Visit in P...
Category : Clinical Trial Update 14 November 2025DBV Technologies, a clinical-stage biopharmaceutical company focused on treatments for food allergie...
Phase 3 Trial of Investigational Heart-Attack Drug...
Category : Clinical Trial Update 14 November 2025Promising data from a pivotal Phase 3 trial of the investigational heart-attack drug zalunfiban (Dis...
Ascletis Announces Co-Formulation of Once-Monthly...
Category : Clinical Trial Update 13 November 2025Highlights Once-monthly co-formulation of amylin receptor agonist ASC36 and dual GLP-1R/GIPR a...
SpyGlass Pharma Reports Positive Results from Clin...
Category : Clinical Trial Update 13 November 202536-month FIH data show sustained IOP reduction and drop-free outcomes Phase I/II trial interim...
Latest Newsletter Post
-
Phase 3 Trial of Investigational He..
14 November 2025
-
DBV Technologies Completes Last Pat..
14 November 2025
-
Fresenius Kabi Issues Voluntary U.S..
14 November 2025
-
Novartis’ GanLum Achieves Phase III..
13 November 2025
-
SpyGlass Pharma Reports Positive Re..
13 November 2025
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com